BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 21984918)

  • 1. c-Rel deficiency increases caspase-4 expression and leads to ER stress and necrosis in EBV-transformed cells.
    Valentín-Acevedo A; Sinquett FL; Covey LR
    PLoS One; 2011; 6(10):e25467. PubMed ID: 21984918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-Myc and Rel/NF-kappaB are the two master transcriptional systems activated in the latency III program of Epstein-Barr virus-immortalized B cells.
    Faumont N; Durand-Panteix S; Schlee M; Grömminger S; Schuhmacher M; Hölzel M; Laux G; Mailhammer R; Rosenwald A; Staudt LM; Bornkamm GW; Feuillard J
    J Virol; 2009 May; 83(10):5014-27. PubMed ID: 19264782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Latent membrane protein 1 of Epstein-Barr virus induces CD83 by the NF-kappaB signaling pathway.
    Dudziak D; Kieser A; Dirmeier U; Nimmerjahn F; Berchtold S; Steinkasserer A; Marschall G; Hammerschmidt W; Laux G; Bornkamm GW
    J Virol; 2003 Aug; 77(15):8290-8. PubMed ID: 12857898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphatidylinositol 3-kinase and NF-kappa B/Rel are at the divergence of CD40-mediated proliferation and survival pathways.
    Andjelic S; Hsia C; Suzuki H; Kadowaki T; Koyasu S; Liou HC
    J Immunol; 2000 Oct; 165(7):3860-7. PubMed ID: 11034392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maintenance of the CD40-related immunodeficient response in hyper-IgM B cells immortalized with a LMP1-regulated mini-EBV.
    Lu KT; Dryer RL; Song C; Covey LR
    J Leukoc Biol; 2005 Sep; 78(3):620-9. PubMed ID: 15961576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-Rel plays a key role in deficient activation of B cells from a non-X-linked hyper-IgM patient.
    Lu KT; Sinquett FL; Dryer RL; Song C; Covey LR
    Blood; 2006 Dec; 108(12):3769-76. PubMed ID: 16896156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined proteasome and Bcl-2 inhibition stimulates apoptosis and inhibits growth in EBV-transformed lymphocytes: a potential therapeutic approach to EBV-associated lymphoproliferative diseases.
    Srimatkandada P; Loomis R; Carbone R; Srimatkandada S; Lacy J
    Eur J Haematol; 2008 May; 80(5):407-18. PubMed ID: 18221384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PACT-mediated PKR activation acts as a hyperosmotic stress intensity sensor weakening osmoadaptation and enhancing inflammation.
    Farabaugh KT; Krokowski D; Guan BJ; Gao Z; Gao XH; Wu J; Jobava R; Ray G; de Jesus TJ; Bianchi MG; Chukwurah E; Bussolati O; Kilberg M; Buchner DA; Sen GC; Cotton C; McDonald C; Longworth M; Ramakrishnan P; Hatzoglou M
    Elife; 2020 Mar; 9():. PubMed ID: 32175843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EBV LMP2A affects LMP1-mediated NF-kappaB signaling and survival of lymphoma cells by regulating TRAF2 expression.
    Guasparri I; Bubman D; Cesarman E
    Blood; 2008 Apr; 111(7):3813-20. PubMed ID: 18230756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear factor kappa B-dependent activation of the antiapoptotic bfl-1 gene by the Epstein-Barr virus latent membrane protein 1 and activated CD40 receptor.
    D'Souza BN; Edelstein LC; Pegman PM; Smith SM; Loughran ST; Clarke A; Mehl A; Rowe M; Gélinas C; Walls D
    J Virol; 2004 Feb; 78(4):1800-16. PubMed ID: 14747545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EBV latency III immortalization program sensitizes B cells to induction of CD95-mediated apoptosis via LMP1: role of NF-kappaB, STAT1, and p53.
    Le Clorennec C; Youlyouz-Marfak I; Adriaenssens E; Coll J; Bornkamm GW; Feuillard J
    Blood; 2006 Mar; 107(5):2070-8. PubMed ID: 16317104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorder.
    Roychowdhury S; Baiocchi RA; Vourganti S; Bhatt D; Blaser BW; Freud AG; Chou J; Chen CS; Xiao JJ; Parthun M; Chan KK; Eisenbeis CF; Ferketich AK; Grever MR; Chen CS; Caligiuri MA
    J Natl Cancer Inst; 2004 Oct; 96(19):1447-57. PubMed ID: 15467034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-Myc dysregulation is a co-transforming event for nuclear factor-κB activated B cells.
    David A; Arnaud N; Fradet M; Lascaux H; Ouk-Martin C; Gachard N; Zimber-Strobl U; Feuillard J; Faumont N
    Haematologica; 2017 May; 102(5):883-894. PubMed ID: 28232371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of Epstein-Barr virus-regulated host gene expression changes through primary B-cell outgrowth reveals delayed kinetics of latent membrane protein 1-mediated NF-κB activation.
    Price AM; Tourigny JP; Forte E; Salinas RE; Dave SS; Luftig MA
    J Virol; 2012 Oct; 86(20):11096-106. PubMed ID: 22855490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular basis of cytotoxicity of Epstein-Barr virus (EBV) latent membrane protein 1 (LMP1) in EBV latency III B cells: LMP1 induces type II ligand-independent autoactivation of CD95/Fas with caspase 8-mediated apoptosis.
    Le Clorennec C; Ouk TS; Youlyouz-Marfak I; Panteix S; Martin CC; Rastelli J; Adriaenssens E; Zimber-Strobl U; Coll J; Feuillard J; Jayat-Vignoles C
    J Virol; 2008 Jul; 82(13):6721-33. PubMed ID: 18448526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. c-Myc Represses Transcription of Epstein-Barr Virus Latent Membrane Protein 1 Early after Primary B Cell Infection.
    Price AM; Messinger JE; Luftig MA
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29118124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintenance of Epstein-Barr Virus Latent Status by a Novel Mechanism, Latent Membrane Protein 1-Induced Interleukin-32, via the Protein Kinase Cδ Pathway.
    Lai KY; Chou YC; Lin JH; Liu Y; Lin KM; Doong SL; Chen MR; Yeh TH; Lin SJ; Tsai CH
    J Virol; 2015 Jun; 89(11):5968-80. PubMed ID: 25810549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling.
    Chen X; Kandasamy K; Srivastava RK
    Cancer Res; 2003 Mar; 63(5):1059-66. PubMed ID: 12615723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide analysis of gene expression in T cells to identify targets of the NF-kappa B transcription factor c-Rel.
    Bunting K; Rao S; Hardy K; Woltring D; Denyer GS; Wang J; Gerondakis S; Shannon MF
    J Immunol; 2007 Jun; 178(11):7097-109. PubMed ID: 17513759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autocrine tumor necrosis factor alpha links endoplasmic reticulum stress to the membrane death receptor pathway through IRE1alpha-mediated NF-kappaB activation and down-regulation of TRAF2 expression.
    Hu P; Han Z; Couvillon AD; Kaufman RJ; Exton JH
    Mol Cell Biol; 2006 Apr; 26(8):3071-84. PubMed ID: 16581782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.